NeuroBo Pharmaceuticals Statistics Share Statistics NeuroBo Pharmaceuticals has 8.62M
shares outstanding. The number of shares has increased by 1.52%
in one year.
Shares Outstanding 8.62M Shares Change (YoY) 1.52% Shares Change (QoQ) 0% Owned by Institutions (%) 4.59% Shares Floating 2.1M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 34.27K, so 0.4% of the outstanding
shares have been sold short.
Short Interest 34.27K Short % of Shares Out 0.4% Short % of Float 1.06% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -4.58 and the forward
PE ratio is -2.05.
NeuroBo Pharmaceuticals's PEG ratio is
-0.1.
PE Ratio -4.58 Forward PE -2.05 PS Ratio 0 Forward PS n/a PB Ratio 15.94 P/FCF Ratio -5.12 PEG Ratio -0.1
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for NeuroBo Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.94,
with a Debt / Equity ratio of 0.02.
Current Ratio 1.94 Quick Ratio 1.94 Debt / Equity 0.02 Debt / EBITDA n/a Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.45M Employee Count 8 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is -0.28, so NeuroBo Pharmaceuticals's
price volatility has been lower than the market average.
Beta -0.28 52-Week Price Change n/a 50-Day Moving Average 2.49 200-Day Moving Average 3.52 Relative Strength Index (RSI) 26.03 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit n/a Operating Income -28.81M Net Income -27.59M EBITDA -28.81M EBIT n/a Earnings Per Share (EPS) -3.56
Full Income Statement Balance Sheet The company has 16.02M in cash and 136K in
debt, giving a net cash position of 15.88M.
Cash & Cash Equivalents 16.02M Total Debt 136K Net Cash 15.88M Retained Earnings -135.86M Total Assets 18.46M Working Capital 9.49M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -24.71M
and capital expenditures -8K, giving a free cash flow of -24.72M.
Operating Cash Flow -24.71M Capital Expenditures -8K Free Cash Flow -24.72M FCF Per Share -0.32
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields NRBO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for NRBO.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 21, 2023. It was a
backward
split with a ratio of 1:8.
Last Split Date Dec 21, 2023 Split Type backward Split Ratio 1:8
Scores Altman Z-Score -12.39 Piotroski F-Score 1
